Skip to content
All Sections
Subscribe Now
70°F
Wednesday, October 1st 2025
e-Edition
Home Page
News
News
Crime and Public Safety
Investigative Reporting
Election
Politics
Health
Environment
Business
Best Reviews
Housing
Jobs
Weather
Local News
Local News
Ontario
Pomona
Chino Valley
Rancho Cucamonga
Claremont
Montclair
Upland
La Verne
San Bernardino County
Los Angeles County
David Allen Column
Sports
Sports
IE Varsity
Chargers
Rams
Lakers
Clippers
Dodgers
Angels
College Sports
UCLA Sports
USC Sports
Kings
Ducks
Olympics
Boxing/MMA
Soccer
Horse Racing
Things To Do
Things To Do
Restaurants Food and Drink
Casinos
Amusement Parks
Movies
Music + Concerts
Theater
TV and Streaming
Home + Garden
Travel
Comics
Events
Obituaries
Obituaries
News Obituaries
Place an Obituary
Opinion
Opinion
Editorials
Opinion Columns
Commentary
Letters to the Editor
Editorial Board
Endorsements
SCNG Premium
Branded Content
Paid Content by Brandpoint
Sponsored Content
The T.E.A.
Subscribe
Daily Bulletin Store
Log In
Logout
Get the latest news delivered daily!
Sign Up
Subscribe
Log In
Account Settings
Contact Us
Log Out
Spoof a user
Get the latest news delivered daily!
Sign Up
Subscribe
Log In
Search
70°F
Wednesday, October 1st 2025
e-Edition
News
Local News
Sports
Obituaries
Things to Do
Opinion
The T.E.A.
Trending:
IE doctor shortageð
Ontario baseball team's name
High school football ð
Oktoberfest ðº
Immigration news
Trump news
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about EXEL
Recent news which mentions EXEL
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Can This Cancer Stock Maintain Its Momentum?
May 18, 2022
Tickers
EXEL
Tags
EXEL
Recent Press Releases
Market News
From
Motley Fool
Buying These 3 Stocks Could Be the Smartest Investing Move You Ever Make
May 17, 2022
Tickers
BMY
ETSY
EXEL
IPSEY
Tags
ETSY
EXEL
Recent Press Releases
From
Motley Fool
Exelixis (EXEL) Q1 2022 Earnings Call Transcript
May 11, 2022
Tickers
EXEL
Tags
Market News
Recent Press Releases
EXEL
From
Motley Fool
Exelixis: Q1 Earnings Insights
May 10, 2022
Tickers
EXEL
Tags
BZI/Recaps
Benzinga
Earnings
From
Benzinga
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
May 10, 2022
Tickers
AGEN
ARWR
ATNX
AVGR
Tags
Small Cap
IBB
Biotech
From
Benzinga
3 Growth Stocks to Buy With $1,000 Right Now
May 03, 2022
Tickers
BMY
CURLF
EXEL
PINS
Tags
CURLF
Market News
BMY
From
Motley Fool
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
May 03, 2022
Tickers
ACAD
AQST
BIIB
BLTE
Tags
BPMC
OCUL
SPRO
From
Benzinga
Ipsen - Exelixis' Cabometyx Scores European Approval As Second-Line Treatment For Thyroid Cancer
May 03, 2022
Tickers
EXEL
IPSEF
IPSEY
Tags
Health Care
IPSEF
News
From
Benzinga
7 Top-Rated Biotech Stocks to Buy for Q2
April 21, 2022
Tickers
BCRX
BNTX
EXEL
ITOS
Tags
ITOS
Market News
RGNX
From
InvestorPlace
Nasdaq Bear Market: 3 of the Safest Stocks to Buy on the Dip
April 13, 2022
Tickers
AVGO
BRK-A
BRK-B
EXEL
Tags
Recent Press Releases
EXEL
^IXIC
From
Motley Fool
3 No-Brainer Stocks to Buy With $1,000 During the Market Sell-Off
April 01, 2022
Tickers
AVGO
EXEL
FB
Tags
Recent Press Releases
EXEL
AVGO
From
Motley Fool
2 Stocks Defying the Market Sell-Off Right Now
March 29, 2022
Tickers
BMY
EXEL
Tags
EXEL
Recent Press Releases
BMY
From
Motley Fool
EMA's Scientific Committee Backs Expanded Use Of Exelixis, Ipsen's Cabometyx In Thyroid Cancer
March 25, 2022
Tickers
EXEL
IPSEF
IPSEY
Tags
IPSEF
European Medicines Agency
Health Care
From
Benzinga
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial
March 15, 2022
Tickers
ALT
ANAB
ANIP
ATHX
Tags
Penny Stocks
TCON
ATNX
From
Benzinga
Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy
March 15, 2022
Tickers
BAYRY
BAYZF
EXEL
IPSEY
Tags
Biotech
Benzinga
Hepatocellular Carcinoma
From
Benzinga
3 Stocks That Can Turn $10,000 Into $50,000 by 2025
March 11, 2022
Tickers
EXEL
FIGS
NVAX
Tags
NVAX
Market News
EXEL
From
Motley Fool
2 Biotech Stocks That Could Make You Richer
March 02, 2022
Tickers
BMY
EXEL
ICPT
RHHBY
Tags
RHHBY
EXEL
ICPT
From
Motley Fool
3 Surefire Stocks to Buy Hand Over Fist During the Stock Market Sell-Off
February 25, 2022
Tickers
EXEL
GM
MA
Tags
MA
Market News
GM
From
Motley Fool
Exelixis (EXEL) Q4 2021 Earnings Call Transcript
February 18, 2022
Tickers
EXEL
Tags
Market News
Recent Press Releases
EXEL
From
Motley Fool
Exelixis: Q4 Earnings Insights
February 17, 2022
Tickers
EXEL
Tags
Market News
Earnings
BZI/Recaps
From
Benzinga
Earnings Scheduled For February 17, 2022
February 17, 2022
Tickers
AAWW
AEE
AEL
AL
Tags
LGND
ROKU
DNOW
From
Benzinga
Earnings Preview For Exelixis
February 16, 2022
Tickers
EXEL
Tags
Benzinga
Market News
BZI/EP
From
Benzinga
Bristol Myers, Exelixis Tout Additional Opdivo/Cabometyx Combo Data From Kidney Cancer Trial
February 15, 2022
Tickers
BMY
EXEL
Tags
renal cell carcinoma
BMY
Market News
From
Benzinga
2 Biotech Stocks That Could Make You Richer
February 02, 2022
Tickers
BLUE
EXEL
TSVT
Tags
EXEL
TSVT
Recent Press Releases
From
Motley Fool
5 Value Stocks That Can Make You Richer in 2022
January 20, 2022
Tickers
AGNC
EXEL
FB
GM
Tags
Market News
EXEL
T
From
Motley Fool
3 Biotech Stocks Wall Street Thinks Could Soar 50% or More in 2022
January 14, 2022
Tickers
ARKG
BMY
CRSP
EXEL
Tags
BMY
ARKG
Market News
From
Motley Fool
A Peek Into The Markets: US Stock Futures Edge Higher; Crude Oil Up 0.5%
January 10, 2022
Tickers
ACN
AZZ
CMC
EXEL
Tags
Benzinga
Markets
Small Cap
From
Benzinga
7 of the Best Cheap Stocks Under $20 for 2022 to Buy Now
January 03, 2022
Tickers
AAL
EXEL
MOMO
ORAN
Tags
NASDAQ:EXEL,NYSE:ORAN,NASDAQ:VOD,NASDAQ:AAL,NASDAQ:MOMO,NASDAQ:VTRS,NASDAQ:SOFI
EXEL
MOMO
From
InvestorPlace
The Daily Biotech Pulse: Novartis Snags Twin FDA Nods, Novavax Positive Vaccine News Continues, Arcutis Psoriasis Application Accepted For Review
December 23, 2021
Tickers
ADAG
ALNY
ARQT
EXEL
Tags
NVAX
FDA
Biotech
From
Benzinga
2 Growth Stocks Analysts Think Can Double Within 2 Years
December 15, 2021
Tickers
EXEL
FUBO
Tags
Recent Press Releases
EXEL
FUBO
From
Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
Close